Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Bedrosian Camille L
Amylyx Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.53%)
Amylyx Pharmaceuticals | 10-Q:2024財年三季報
Amylyx Pharmaceuticals | 8-K:Amylyx Pharmicals公佈2024年第三季度財務業績
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Klee Justin B.
Amylyx Pharmaceuticals | SC 13G:超過5%持股股東披露文件-The Vanguard Group(4.53%)
Amylyx Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Perceptive Advisors LLC(6.5%),Joseph Edelman(6.5%)等
Amylyx Pharmaceuticals | 8-K:重大事件
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Klee Justin B.
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Bedrosian Camille L
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Mazzariello Gina
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4/A:持股變動聲明(修正)-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 MILNE GEORGE M JR
Amylyx Pharmaceuticals | SC 13G:超過5%持股股東披露文件-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%)等
Amylyx Pharmaceuticals | 10-Q:2024財年二季報
暫無數據